Exact Sciences to be Acquired by Abbott Laboratories for $105.00 Per Share in All-Cash Deal

summarizeSummary

Exact Sciences Corporation is set to be acquired by Abbott Laboratories for $105.00 per share in cash, a transaction unanimously recommended by Exact Sciences' Board of Directors.

check_boxKey Events

• Acquisition Agreement

  Exact Sciences Corporation entered into a definitive merger agreement to be acquired by Abbott Laboratories.

• Per Share Consideration

  Shareholders will receive $105.00 in cash for each share of common stock.

• Significant Premium

  The offer represents a premium of approximately 51% over the unaffected closing share price on November 18, 2025, and 77% over the 60-day volume-weighted average price.

• Board Recommendation

  Exact Sciences' Board of Directors unanimously recommends that stockholders vote to adopt the merger agreement.

auto_awesomeAnalysis

This DEFM14A filing announces a definitive agreement for Abbott Laboratories to acquire Exact Sciences Corporation for $105.00 per share in an all-cash transaction. This represents a substantial premium to Exact Sciences' recent trading prices, including a 51% premium over the unaffected closing price on November 18, 2025, and a 77% premium over the 60-day volume-weighted average price. The offer price of $105.00 is also above the current stock price of $101.78 and the 52-week high of $102.66, indicating a favorable exit for shareholders. The Board of Directors has unanimously recommended the merger, highlighting the certainty of value and liquidity for stockholders while eliminating long-term business and execution risks. The acquisition by a global healthcare leader like Abbott provides a strong strategic rationale, potentially accelerating the growth and adoption of Exact Sciences' innovative offerings. The transaction is not subject to a financing condition, reducing execution risk. Shareholders will vote on the merger on February 20, 2026, with the deal expected to close before the end of Q2 2026.